This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

MLS Makes Bid for Relevance

On Saturday night, I will attend the game between Real Madrid and Real Salt Lake.

Win or lose, MLS Commissioner Don Garber hopes such high-profile games can elevate the stature of the MLS, which has lost more than $350 million in the past decade.

Garber points to recent business announcements, and predicts the 10-year-long money slide will end. He says that with the marketing strategy of the MLS, along with a new broadcast partnership with ESPN, more American sports enthusiasts than ever will be exposed -- and begin to appreciate -- soccer, the world's most popular sport. The 2006 World Cup, in which Italy defeated France, attacted a sizable TV audience in America.

Real Salt Lake, which joined the MLS in 2005, has threatened to leave the city because local elected officials recently refused to invest $35 million in taxpayer money toward building the team a 20,000-seat soccer stadium. The team plays at the University of Utah's Rice-Eccles Stadium, a 45,000-seat football venue with artificial turf.

Elected officials in Salt Lake City expressed skepticism about the feasibility of the stadium deal. A Real Salt Lake business plan, submitted with the request for the public money, showed the team continuing to lose money, and only making money in the near future by hosting an ambitious schedule of music concerts and selling naming rights. The plan projected season ticket sales doubling from 6,000 this year to 12,500 in 2015.

2 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs